Positron Emission Tomography (PET) studies rely on a specialized tracer to visualize metabolic activity within the body. This tracer, 2-deoxyglucose, is a modified sugar molecule that accumulates in areas of high metabolic demand. By administering FDG into the bloodstream and tracking its distribution through PET scanners, clinicians can observe a